This slide provides guidelines
for safe and effective warfarin use. The dose of warfarin
should be monitored daily until the INR is in the therapeutic
range and thenless
frequently when a stable dose-response relationship is achieved.
Regardless of the degree of stability in warfarin dosing and
INR value in the hospital, it is important to monitor the
INR frequently post hospital discharge (i.e., at least 1–3
days after discharge) and to spread out the interval of monitoring
thereafter depending on INR response. Monitoring is necessary
in all patients, but can be reduced to four weekly intervals
in the low risk (for bleeding) patient who shows a stable
dose-response.
The content of these pages is
from a presentation called "Management of Oral
Anticoagulant Therapy: Principles & Practice,"
prepared by the American Heart Association's Post-Graduate
Education Committee of the Council on Clinical Cardiology.
Supported by an educational grant from DuPont Pharmaceuticals.
Authors: Jack Ansell, M.D., Jack
Hirsch, M.D., Nanette K. Wenger, M.D.
Data current as of October 1999.
Endorsed by the Anticoagulation
Forum and the American Heart Association Council on Atherosclerosis,
Thrombosis, and Vascular Biology.
The information in this
web site is not a substitute for medical advice or treatment.
Consultation with your doctor or health care professional is recommended.